Answers are grounded in this paper and cite their sources.
A Δ4‐3‐ketosteroid 5β‐reductase active on 7α‐hydroxycholest‐4‐en‐3‐one and 7α,12α‐di‐hydroxycholest‐4‐en‐3‐one and a 3α‐hydroxysteroid dehydrogenase active on 7α‐hydroxy‐5β‐cholestan‐3‐one and 7α,12α‐dihydroxy‐5β‐cholestan‐3‐one have been isolated from the soluble fraction of a rat liver homogenate and have been partially purified by chromatography on TEAE‐cellulose and Sephadex G‐75. The Δ4‐3‐ketosteroid 5β‐reductase required NADPH as cofactor and was inhibited reversibly by p‐chloromercuribenzoate. The enzyme preparation catalyzed the reduction of the double bond in a number of Δ4‐3‐ketosteroids of the C19, C21, C24, and C27 series. The reduction of 7α,12α‐dihydroxycholest‐4‐en‐3‐one in the presence of the Δ4‐3‐ketosteroid 5β‐reductase preparation was not inhibited by addition of 7α‐hydroxycholest‐4‐en‐3‐one and the reduction of 7α‐hydroxycholest‐4‐en‐3‐one was not inhibited by 7α,12α‐dihydroxycholest‐4‐en‐3‐one indicating that these substrates were reduced by different reductases present in the Δ4‐3‐ketosteroid 5β‐reductase preparation. The 3α‐hydroxysteroid dehydrogenase required reduced pyridine nucleotide, NADPH being preferred, and was inhibited reversibly by p‐chloromercuribenzoate. The enzyme preparation catalyzed the reduction of the 3‐keto group in a number of 3‐ketosteroids of the C19, C21, C24, and C27 series. The rate of reduction was faster with 3‐keto‐5β‐steroids than with the corresponding 3‐keto‐5α‐steroids.
No takes yet. Share an insight, caveat, or question.
Olle Berséus (1967) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: